Lv51
1160 积分 2021-09-01 加入
结核分枝杆菌的生物学特性与致病机制研究
1小时前
已完结
Treating Relapsed / Refractory (RR) AML with Biodegradable Anti-CD123 CAR Modified T Cells
2个月前
已关闭
Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering
2个月前
已完结
Organoid models: the future companions of personalized drug development
3个月前
已完结
AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells
3个月前
已完结
Delivering mRNA to a human NK cell line, NK-92 cells, by lipid nanoparticles
3个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
3个月前
已完结
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
3个月前
已完结
Phase 1b/2a randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with chronic hepatitis B
4个月前
已完结
The scientific basis of combination therapy for chronic hepatitis B functional cure
4个月前
已完结
皖公网安备34019202002308
